Search

Stryker Corp

Открыт

СекторЗдравоохранение

337.76 -0.9

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

334.39

Макс.

341.74

Ключевые показатели

By Trading Economics

Доход

531M

1.3B

Продажи

569M

6.6B

P/E

Средняя по отрасли

35.072

57.002

Прибыль на акцию

3.69

Дивидендная доходность

1.03

Рентабельность продаж

19.366

Сотрудники

56,000

EBITDA

266M

1.6B

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+12.82% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

1.03%

2.22%

Следующий отчет о доходах

29 окт. 2026 г.

Дата следующей выплаты дивидендов

30 окт. 2026 г.

Следующая эксдивидендная дата

29 сент. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

3.6B

133B

Предыдущая цена открытия

338.66

Предыдущая цена закрытия

337.76

Новостные настроения

By Acuity

61%

39%

296 / 340 Рейтинг в Healthcare

Stryker Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

13 авг. 2026 г., 20:06 UTC

News

Stryker Corp shares declined following Wolfe Research's downgrade to Peer Perform, citing a challenging outlook and tempered growth expectations for the second half of the year.

12 авг. 2026 г., 19:16 UTC

Stryker Corp. shares are lower amid geopolitical tensions and rising crude oil prices, despite remaining above their 20-day moving average.

11 авг. 2026 г., 23:26 UTC

Stryker Corp. shares declined in after-market trading, reflecting broader market trends amid cautious investor sentiment and lower oil prices.

10 авг. 2026 г., 23:06 UTC

Stryker Corp shares are higher in after-market trading, continuing a trend above the 20-day moving average after three consecutive sessions of gains.

7 авг. 2026 г., 20:06 UTC

Stryker Corp shares are higher, supported by declining Treasury yields after July's unemployment rate fell to 4.1%. Earlier, the stock pulled back from session lows.

6 авг. 2026 г., 20:06 UTC

Macro Event
News

Stryker Corp shares are lower as supply chain disruptions impact sales, despite meeting revenue expectations of $6.59 billion and adjusted EPS of $3.69.

5 авг. 2026 г., 23:12 UTC

Stryker Corp shares are lower in after-market hours, reflecting unusual trading behavior and a decline in momentum since Wednesday's close. No specific news was identified.

4 авг. 2026 г., 19:56 UTC

Stryker Corp shares are lower today, reflecting broader market trends amid a significant drop in crude oil prices since Monday's close.

3 авг. 2026 г., 20:03 UTC

News

Stryker Corp shares are higher as Citizens lowers its price target to $400, citing strong Q2 revenue growth despite supply chain challenges.

31 июл. 2026 г., 23:16 UTC

Stryker Corp shares are higher in after-market trading, showing some volatility. No specific company news has been identified to explain the movement.

30 июл. 2026 г., 23:41 UTC

Social Media
News

Stryker Corp shares fell in after-market trading despite reporting adjusted EPS of $3.69 and raising full-year guidance to $14.95 to $15.10.

29 июл. 2026 г., 22:41 UTC

Stryker Corp shares are lower in after-market trading, reversing from earlier gains. The stock remains above its 20-day moving average.

28 июл. 2026 г., 20:51 UTC

Stryker Corp shares are lower in after-market trading, reversing earlier gains. The stock remains above its 20-day moving average.

27 июл. 2026 г., 19:06 UTC

Social Media
News
Correlated Moves

Stryker Corp shares reached a 13-week high today, trading higher alongside broader gains in the medical technology sector, including Intuitive Surgical's notable increase.

24 июл. 2026 г., 23:36 UTC

Stryker Corp shares are lower in after-market hours, with no specific news identified. Market sentiment reflects cautious optimism amid a decrease in initial jobless claims.

22 июл. 2026 г., 20:46 UTC

Stryker Corp. shares are higher in after-market trading, rebounding from recent declines, though still below the 20-day moving average.

21 июл. 2026 г., 18:16 UTC

Stryker Corp shares are lower today, following a dip that reached nearly -2%. The stock remains below its 20-day moving average.

20 июл. 2026 г., 20:41 UTC

Stryker Corp shares are lower in after-market hours with no specific news identified. Broader market dynamics include a decline in the US 10Y Treasury yield.

Сравнение c конкурентами

Изменение цены

Stryker Corp Прогноз

Целевая цена

By TipRanks

12.82% рост

Прогноз на 12 месяцев

Средняя 384.82 USD  12.82%

Максимум 455 USD

Минимум 340 USD

Основано на мнении 18 аналитиков Wall Street, спрогнозировавших целевые цены для Stryker Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

18 ratings

16

Покупка

2

Удержание

0

Продажа

Настроения

By Acuity

296 / 340Рейтинг в Здравоохранение

Новостные настроения

Свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat